Data from wearables is often siloed by device makers and disease. Agile Metabolic Health, powered by JupyterHealth, offers an open platform for secure sensor data collection and digital biomarker development. With an open-source ethos, JupyterHealth fosters collaboration, real-time insights, and personalized diabetes management, aiming to expand to other chronic conditions for broader impact.
December 6, 2023
The latest edition of the Model List of Essential Medicines (EML), published on July 26, 2023, now includes acamprosate and naltrexone for treating alcohol use disorders in adults. Alcohol use disorders affect nearly 300 million people worldwide, contributing to 3 million deaths annually. This marks the first time any medications for alcohol use disorders have been included, reflecting the recognition of their public health importance and treatment effectiveness.
August 8, 2023
- AMA Doc Talk
December 26, 2018
- Mount Sinai Health System
September 25, 2018
- POLITICO New York Health Care
February 1, 2018
- Crain's Health Pulse
February 1, 2018
- Mount Sinai Health System
February 1, 2018
- The Indian EYE
July 29, 2016
- POLITICO New York Health Care
July 18, 2016
- Mount Sinai Health System
July 15, 2016
- The Lancet
December 12, 2015
- India-West
August 5, 2015
- The Indian Express
May 16, 2015
- Yale News
September 22, 2014
- United Nations
July 11, 2014
- PLOS Translational Global Health
July 10, 2014
- News From Weill Cornell
May 23, 2014
- News From Weill Cornell
February 26, 2014
- Weill Cornell Medicine
Spring 2013
- TEDMED Blog
January 30, 2013
- India-West
July 31, 2012
- News From Weill Cornell
June 15, 2012
- PBS NewsHour
September 19, 2011
- British Medical Journal
August 23, 2011
- The Indian Express
June 29, 2011
- Inspiring Lives, Scientific American
Fall 2010
- The Chronicle of Higher Education
July 25, 2007
- Cornell Chronicle
February 23, 2007
